Free light chain determination reagent for diagnosing multiple myeloma
The invention discloses a free light chain determination reagent for diagnosing multiple myeloma, and relates to the technical field of determination reagents, the free light chain determination reagent comprises a specific primer pair A and a probe A; the specific primer pair A is a primer pair com...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses a free light chain determination reagent for diagnosing multiple myeloma, and relates to the technical field of determination reagents, the free light chain determination reagent comprises a specific primer pair A and a probe A; the specific primer pair A is a primer pair composed of DNA as shown in a sequence 1 of a sequence table and DNA as shown in a sequence 2 of the sequence table; the nucleotide sequence of the probe A is shown as a sequence 3 in the sequence table, and the positive plasmid contains an NY-ESO-1 gene. According to the free light chain determination reagent for diagnosing multiple myeloma, the NY-ESO-1 gene is expressed in bone marrow or peripheral blood of many multiple myeloma patients, the NY-ESO-1 gene is not expressed in bone marrow or peripheral blood of normal people, and the positive rates of the NY-ESO-1 gene are different in bone marrow or peripheral blood of multiple myeloma patients in different ISS stages. The reagent can be applied to qualitative auxi |
---|